The EDGE

David C Seldin, MD, PhD: scientist, clinician, teacher, gentleman, 1957–2015

V Sanchorawala and R P Gale

Bone Marrow Transplant 2016 51: 323; 10.1038/bmt.2015.340

Reviews

New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT

X Chang, X Zang and C-Q Xia

Bone Marrow Transplant 2016 51: 324-332; advance online publication, November 23, 2015; 10.1038/bmt.2015.288

Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?

J J Auletta, S M Devine and E K Waller

Bone Marrow Transplant 2016 51: 333-343; advance online publication, December 7, 2015; 10.1038/bmt.2015.301

Commentaries

HLA-identical siblings versus haploidentical donors: full match still beats half match

R Hanna and N S Majhail

Bone Marrow Transplant 2016 51: 344-345; advance online publication, December 7, 2015; 10.1038/bmt.2015.291

Invasive aspergillosis before HCT: safe to proceed?

R K Avery

Bone Marrow Transplant 2016 51: 346-347; advance online publication, December 14, 2015; 10.1038/bmt.2015.302

Mobilization policy in multiple myeloma: minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean

A Olivieri and F Saraceni

Bone Marrow Transplant 2016 51: 348-350; advance online publication, December 21, 2015; 10.1038/bmt.2015.317

Original Articles

ACUTE LEUKEMIA

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

X Cahu, M Labopin, S Giebel, M Aljurf, S Kyrcz-Krzemien, G Socié, M Eder, F Bonifazi, D Bunjes, S Vigouroux, M Michallet, M Stelljes, T Zuckerman, J Finke, J Passweg, I Yakoub-Agha, D Niederwieser, G Sucak, H Sengeløv, E Polge, A Nagler, J Esteve and M Mohty on behalf of the Acute Leukemia Working Party of EBMT

Bone Marrow Transplant 2016 51: 351-357; advance online publication, November 30, 2015; 10.1038/bmt.2015.278

LYMPHOMA

Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

A-C Mamez, V Lévy, P Chevallier, D Blaise, S Vigouroux, A Xhaard, N Fegueux, N Contentin, Y Beguin, N Ifrah, C-E Bulabois, F Suarez, I Yakoub-Agha, P Turlure, E Deconink, T Lamy, J Y Cahn, A Huynh, S Maury, L M Fornecker, M Ouzegdouh, J-O Bay, G Guillerm, N Maillard, M Michallet, J-V Malfuson, J-H Bourhis, F Rialland, R Oumedaly, C Jubert, V Leblond, M Boubaya, M Mohty and S Nguyen

Bone Marrow Transplant 2016 51: 358-364; advance online publication, November 23, 2015; 10.1038/bmt.2015.280

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party

S P Robinson, A Boumendil, H Finel, D Blaise, X Poiré, E Nicolas-Virelizier, R Or, R Malladi, A Corby, L Fornecker, D Caballero, D Pohlreich, A Nagler, C Thieblemont, J Finke, E Bachy, L Vincent, W Schroyens, H Schouten and P Dreger

Bone Marrow Transplant 2016 51: 365-371; advance online publication, November 30, 2015; 10.1038/bmt.2015.286

PLASMA CELL DISORDERS

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma OPEN

R Silvennoinen, P Anttila, M Säily, T Lundan, J Heiskanen, T M Siitonen, S Kakko, M Putkonen, H Ollikainen, V Terävä, A Kutila, K Launonen, A Räsänen, A Sikiö, M Suominen, P Bazia, K Kananen, T Selander, T Kuittinen, K Remes and E Jantunen

Bone Marrow Transplant 2016 51: 372-376; advance online publication, October 5, 2015; 10.1038/bmt.2015.236

INHERITED AND GENETIC DISORDERS

Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients OPEN

M Ansari, P Huezo-Diaz, M A Rezgui, S Marktel, M Duval, H Bittencourt, B Cappelli and M Krajinovic

Bone Marrow Transplant 2016 51: 377-383; advance online publication, December 21, 2015; 10.1038/bmt.2015.321

SOLID CANCERS

Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party

A Necchi, R Miceli, M Bregni, C Bokemeyer, L A Berger, K Oechsle, K Schumacher, E Kanfer, J H Bourhis, C Massard, D Laszlo, J Montoro, A Flechon, F Arpaci, S Secondino, P Wuchter, P Dreger, M Crysandt, N Worel, W Kruger, M Ringhoffer, A Unal, A Nagler, A Campos, A Wahlin, M Michieli, G Sucak, I Donnini, R Schots, N Ifrah, M Badoglio, M Martino, D Raggi, P Giannatempo, G Rosti, P Pedrazzoli and F Lanza on behalf of the EBMT Solid Tumors Working Party

Bone Marrow Transplant 2016 51: 384-390; advance online publication, December 7, 2015; 10.1038/bmt.2015.300

GRAFT SOURCE

Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation

C-H Yan, L-P Xu, F-r Wang, H Chen, W Han, Yu Wang, J-z Wang, K-Y Liu and X-J Huang

Bone Marrow Transplant 2016 51: 391-397; advance online publication, December 21, 2015; 10.1038/bmt.2015.306

CONDITIONING

Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations

E Snarski, A Milczarczyk, K Hałaburda, T Torosian, M Paluszewska, E Urbanowska, M Król, P Boguradzki, K Jedynasty, E Franek and W Wiktor-Jedrzejczak

Bone Marrow Transplant 2016 51: 398-402; advance online publication, December 7, 2015; 10.1038/bmt.2015.294

TRANSPLANT TOXICITIES

Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes

K Yakushijin, Y Atsuta, N Doki, A Yokota, H Kanamori, T Miyamoto, C Ohwada, K Miyamura, Y Nawa, M Kurokawa, I Mizuno, T Mori, M Onizuka, J Taguchi, T Ichinohe, H Yabe, Y Morishima, K Kato, R Suzuki and T Fukuda

Bone Marrow Transplant 2016 51: 403-409; advance online publication, November 23, 2015; 10.1038/bmt.2015.283

GRAFT-VERSUS-HOST DISEASE

A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation

K Riesner, M Kalupa, Y Shi, S Elezkurtaj and O Penack

Bone Marrow Transplant 2016 51: 410-417; advance online publication, November 23, 2015; 10.1038/bmt.2015.279

INFECTIONS

Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties

O Penack, G Tridello, J Hoek, G Socié, D Blaise, J Passweg, P Chevallier, C Craddock, N Milpied, H Veelken, J Maertens, P Ljungman, J Cornelissen, A Thiebaut-Bertrand, B Lioure, M Michallet, S Iacobelli, A Nagler, M Mohty and S Cesaro

Bone Marrow Transplant 2016 51: 418-423; advance online publication, October 26, 2015; 10.1038/bmt.2015.237

Letters to the Editor

Haploidentical hematopoietic stem cell transplantation for nonresponders to immunosuppressive therapy against acquired severe aplastic anemia

L Liu, X Wang, S Jin, L Hao, Y Zhang, X Zhang and D Wu

Bone Marrow Transplant 2016 51: 424-427; advance online publication, October 19, 2015; 10.1038/bmt.2015.249

Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors

M Lindemann, M Koldehoff, M Fiedler, A Schumann, H D Ottinger, F M Heinemann, M Roggendorf, P A Horn and D W Beelen

Bone Marrow Transplant 2016 51: 428-431; advance online publication, October 26, 2015; 10.1038/bmt.2015.253

Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma

S Haji, J Kiyasu, I Choi, Y Suehiro, K Toyoda, M Tsuda, A Takamatsu, Y Nakashima, H Miyoshi, M Shiratsuchi, S Yamasaki, N Uike and Y Abe

Bone Marrow Transplant 2016 51: 432-434; advance online publication, November 2, 2015; 10.1038/bmt.2015.254

Factors associated with post-traumatic stress symptoms experienced in the acute phase following haemopoietic stem cell transplant

B Pillay, S J Lee, L Katona, S De Bono, S Burney and S Avery

Bone Marrow Transplant 2016 51: 435-437; advance online publication, November 2, 2015; 10.1038/bmt.2015.259

TCRαβ CD19 depletion in allogeneic haematopoietic stem cell transplantation performed for Hurler syndrome

C Mainardi, M Tumino, M V Gazzola, A Rampazzo, M Scarpa and C Messina

Bone Marrow Transplant 2016 51: 438-439; advance online publication, November 9, 2015; 10.1038/bmt.2015.258

Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies

S Masouridi-Levrat, A Pradier, F Simonetta, L Kaiser, Y Chalandon and E Roosnek

Bone Marrow Transplant 2016 51: 440-442; advance online publication, November 9, 2015; 10.1038/bmt.2015.262

Nivolumab in a patient with refractory Hodgkin’s lymphoma after allogeneic stem cell transplantation

L Angenendt, C Schliemann, M Lutz, E Rebber, A B Schulze, M Weckesser, L Stegger, M Schäfers, C Groth, T Kessler, G Lenz, M Stelljes and W E Berdel

Bone Marrow Transplant 2016 51: 443-445; advance online publication, November 9, 2015; 10.1038/bmt.2015.266

Analytic morphomics: a novel CT imaging approach to quantify adipose tissue and muscle composition in allogeneic hematopoietic cell transplantation

K Chughtai, Y Song, P Zhang, B Derstine, E Gatza, J Friedman, L Hully, C Inglis, S Goldstein, J Magenau, A Pawarode, P Reddy, M Riwes, G Yanik, S C Wang and S W Choi

Bone Marrow Transplant 2016 51: 446-450; advance online publication, November 9, 2015; 10.1038/bmt.2015.267

A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F

S Fuji, S-W Kim, S Yano, S Hagiwara, H Nakamae, M Hidaka, T Ito, K Ohashi, K Hatanaka, A Takami, S Kurosawa, T Yamashita, T Yamaguchi and T Fukuda

Bone Marrow Transplant 2016 51: 451-453; advance online publication, November 9, 2015; 10.1038/bmt.2015.268

Acute myeloid leukemia presenting with extensive bone marrow necrosis, leukemia cutis and testicular involvement: successful treatment with allogeneic hematopoietic stem cell transplantation

A Rashidi, J F DiPersio, P Westervelt, C N Abboud and R Romee

Bone Marrow Transplant 2016 51: 454-455; advance online publication, November 9, 2015; 10.1038/bmt.2015.272

Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study

M Wu, J Sun, Y Zhang, F Huang, H Zhou, Z Fan, L Xuan, G Yu, X Guo, M Dai, R Feng and Q Liu

Bone Marrow Transplant 2016 51: 456-458; advance online publication, November 23, 2015; 10.1038/bmt.2015.281

Acute pericarditis before engraftment in hematopoietic stem cell transplantation

A Shinohara, A Honda, A Nukina, K Takaoka, A Tsukamoto, S Hangai, Y Kogure, T Kobayashi, S Yamazaki, K Ueda, F Nakamura, Y Nannya and M Kurokawa

Bone Marrow Transplant 2016 51: 459-461; advance online publication, November 23, 2015; 10.1038/bmt.2015.282

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

L Castagna, S Bramanti, S Furst, L Giordano, B Sarina, R Crocchiolo, J El Cheikh, A Granata, L Morabito, E Mauro, C Faucher, B Mohty, S Harbi, R Devillier, C Chabannon, C Carlo-Stella, A Santoro and D Blaise

Bone Marrow Transplant 2016 51: 462-465; advance online publication, November 23, 2015; 10.1038/bmt.2015.289

Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse

E Xue, C Tresoldi, E Sala, A Crippa, B Mazzi, R Greco, C Messina, M G Carrabba, M T Lupo Stanghellini, S Marktel, C Corti, J Peccatori, M Bernardi, F Ciceri and L Vago

Bone Marrow Transplant 2016 51: 466-469; advance online publication, December 7, 2015; 10.1038/bmt.2015.296

Erratum

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

L Castagna, S Bramanti, S Furst, L Giordano, B Sarina, R Crocchiolo, J El-Cheikh, A Granata, L Morabito, E Mauro, C Faucher, B Mohty, S Harbi, R Devillier, C Chabannon, C Carlo-Stella, A Santoro and D Blaise

Bone Marrow Transplant 2016 51: 470; 10.1038/bmt.2015.327